What is Crescita Therapeutics Price-to-Operating-Cash-Flow?
As of today (2024-05-11), Crescita Therapeutics's share price is C$0.435.
Crescita Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.10. Hence, Crescita Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is 4.26.
The historical rank and industry rank for Crescita Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:
TSX:CTX'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.97 Med: 5.27 Max: 177.5
Current: 4.26
During the past 10 years, Crescita Therapeutics's highest Price-to-Operating-Cash-Flow Ratio was 177.50. The lowest was 1.97. And the median was 5.27.
Crescita Therapeutics's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was C$-0.01.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.10.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -27.40% per year.
During the past 10 years, Crescita Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 60.50% per year. The lowest was -27.40% per year. And the median was 7.40% per year.
Crescita Therapeutics Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Crescita Therapeutics's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Crescita Therapeutics Price-to-Operating-Cash-Flow Chart
|
Crescita Therapeutics Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
3.94 |
2.62 |
- |
- |
4.80 |
|
Crescita Therapeutics Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
22.41 |
22.41 |
48.46 |
4.80 |
Competitive Comparison of Crescita Therapeutics's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Crescita Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Crescita Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Crescita Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Crescita Therapeutics's Price-to-Operating-Cash-Flow falls into.
Crescita Therapeutics Price-to-Operating-Cash-Flow Calculation
Crescita Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 0.435 | / | 0.102 |
| = | 4.26 |
Crescita Therapeutics's Share Price of today is C$0.435.
Crescita Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Crescita Therapeutics (TSX:CTX) Business Description
Traded in Other Exchanges
Address
2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3
Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue in the form of product sales and out-licensing revenue.
Crescita Therapeutics (TSX:CTX) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSX:CTX has been successfully added to your